Q: The Globe published this, "Scotiabank analyst Ben Isaacson initiated coverage of MediPharm Labs Corp. with a “sector outperform” rating and $17 target. The average is $7.35."
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)